Category: AI and machine learning

October 8, 2026
Where drug discovery loses time, and how to win it back
Scattered structural data slows early drug discovery. See how the right drug discovery software helps teams find, trust and reuse the data they hold.
July 20, 2026
Reflections from Bio 2026
Moving past the AI hype in drug discovery
July 20, 2026
What twenty-five years taught us about protein structure data
How a major pharmaceutical collaboration highlighted the critical need for interrogable data pipelines in the era of machine learning
June 9, 2026
Proasis doesn't hallucinate
Why scientific judgement still matters in AI-driven drug discovery
June 9, 2026
The business case reshaping drug discovery
Seoul in late April moves at a pace that feels appropriate for a city hosting one of Asia’s most significant life sciences gatherings. BioKorea 2026 drew dealmakers, investors, and business development executives from across the globe
June 9, 2026
The science of BioKorea 2026
Why AI in drug discovery still depends on data quality and biology